A recent study has shed light on the potential health and dental risks associated with GLP-1 agonists, a class of medications commonly used for weight loss. These medications, which include Ozempic, work by regulating blood sugar levels and aiding in weight loss. However, researchers are now investigating the potential side effects of these drugs, particularly in relation to oral health.
According to Dr. Sofina Ahmed, a dentist at Viva Dental, GLP-1 agonists can have a significant impact on the mouth and teeth. The medication can cause dry mouth, reducing saliva production and leaving teeth vulnerable to disease and decay. This can lead to a range of oral health issues, including fungal infections, ulcers, and tooth decay.
Furthermore, patients taking GLP-1 agonists have reported increased tooth pain when consuming hot, cold, or sweet foods and drinks. If left untreated, this can lead to enamel erosion or receding gums, which can negatively impact the appearance of the smile and face.
Dr. Ahmed recommends that individuals taking GLP-1 agonists take steps to mitigate these risks. Drinking water consistently, sucking on sugar-free mints and gum, and using fluoride-rich toothpaste can help to promote saliva production and protect teeth. It’s also essential to inform your dentist if you’re taking GLP-1 agonists, as this can affect treatment decisions and monitoring plans.
By being aware of these potential risks and taking proactive steps, individuals can minimize the negative effects of GLP-1 agonists on their oral health and maintain a healthy, beautiful smile.
